Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.
2.

Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.

Yang CW, Wang CW, Hong RL, Tsai CL, Yao M, Tang JL, Lin CW, Cheng AL, Kuo SH.

J Radiat Res. 2017 Jan;58(1):114-122. doi: 10.1093/jrr/rrw081. Epub 2016 Aug 16.

3.

Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.

Niu SQ, Yang Y, Li YY, Wen G, Wang L, Li ZM, Wang HY, Zhang LL, Xia YF, Zhang YJ.

Chin J Cancer. 2016 Apr 4;35:34. doi: 10.1186/s40880-016-0096-0.

4.

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.

Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS, Yhim HY, Kwak JY, Do YR, Park Y, Song MK, Shin HJ, Kim T, Lee JJ, Yang DH.

Leuk Res. 2016 Oct;49:80-7. doi: 10.1016/j.leukres.2016.08.015. Epub 2016 Aug 31.

PMID:
27608179
5.

Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.

Dong LH, Zhang LJ, Wang WJ, Lei W, Sun X, Du JW, Gao X, Li GP, Li YF.

Leuk Lymphoma. 2016 Jul;57(7):1600-6. doi: 10.3109/10428194.2015.1108415. Epub 2016 Jan 4.

PMID:
26726970
6.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.

Oral Oncol. 2008 Jan;44(1):23-30. Epub 2007 Feb 15.

PMID:
17306611
7.

Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.

Michot JM, Mazeron R, Danu A, Lazarovici J, Ghez D, Antosikova A, Willekens C, Chamseddine AN, Minard V, Dartigues P, Bosq J, Carde P, Koscielny S, De Botton S, Ferme C, Girinsky T, Ribrag V.

Eur J Cancer. 2015 Nov;51(16):2386-95. doi: 10.1016/j.ejca.2015.07.009. Epub 2015 Aug 5.

PMID:
26254810
8.
9.

The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.

Kim TH, Kim JS, Suh YG, Cho J, Yang WI, Suh CO.

Yonsei Med J. 2016 Jul;57(4):846-54. doi: 10.3349/ymj.2016.57.4.846.

10.

Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.

Oh D, Ahn YC, Kim SJ, Kim WS, Ko YH.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):677-83. doi: 10.1016/j.ijrobp.2015.07.2267. Epub 2015 Jul 22.

PMID:
26461010
11.
12.

Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma.

Tsai HJ, Lin SF, Chen CC, Chen TY, Su WC, Hwang WL, Lin JC, Chiou TJ, Kao WY, Chiu CF, Chang YF, Chang JS, Chang MC, Su IJ.

Eur J Haematol. 2015 Feb;94(2):130-7. doi: 10.1111/ejh.12405. Epub 2014 Oct 10.

PMID:
24957163
13.

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS.

J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2.

PMID:
19884539
14.

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.

Wang ZY, Li YX, Wang WH, Jin J, Wang H, Song YW, Liu QF, Wang SL, Liu YP, Qi SN, Fang H, Liu XF, Yu ZH.

Blood. 2009 Nov 26;114(23):4771-6. doi: 10.1182/blood-2009-07-235853. Epub 2009 Oct 7.

15.

A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.

Cao J, Lan S, Shen L, Si H, Zhang N, Li H, Guo R.

Oncotarget. 2017 Mar 21;8(12):20362-20370. doi: 10.18632/oncotarget.13614.

16.

Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.

Zang J, Li C, Luo SQ, Wang JH, Xu M, Zhao LN, Li WW, Yang H, Xiao F, Hitchcock YJ, Shi M.

Ann Hematol. 2015 Apr;94(4):583-91. doi: 10.1007/s00277-014-2244-4. Epub 2014 Nov 21.

PMID:
25409913
17.

Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma.

Wang ZY, Li YX, Wang H, Wang WH, Jin J, Liu YP, Song YW, Wang SL, Liu XF, Yu ZH.

Ann Oncol. 2011 Feb;22(2):390-6. doi: 10.1093/annonc/mdq347. Epub 2010 Jul 8.

PMID:
20616195
18.

Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract.

Fang H, Jin J, Wang WH, Wang SL, Zhou LQ, Li YX.

Leuk Lymphoma. 2014 Aug;55(8):1832-7. doi: 10.3109/10428194.2013.852668. Epub 2014 Feb 4.

PMID:
24144309
19.

Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.

Tababi S, Kharrat S, Sellami M, Mamy J, Zainine R, Beltaief N, Sahtout S, Besbes G.

Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Jun;129(3):141-7. doi: 10.1016/j.anorl.2011.08.004. Epub 2012 Feb 7.

20.

[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].

Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF.

Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):58-61. Chinese.

PMID:
16737624

Supplemental Content

Support Center